Back to Noidecs or All Bud/Flower

Dosing Look-Up Table (Estimated)

0.01/g0.8/mg THC0.8/mg CBD
0.05/g4/mg THC4/mg CBD
0.1/g8/mg THC8/mg CBD
0.15/g12/mg THC12/mg CBD
0.2/g16/mg THC16/mg CBD
0.25/g20/mg THC20/mg CBD
0.3/g24/mg THC24/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United Kingdom Noidecs
Designation
T8:C8
Cultivar/Strain
Balanced Caramel
Classification
Hybrid
Chemotype
Type II: THC/CBD Mix
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
7.2-8.8%
CBD Potential Range (±10%)
8%
Cultivated/Produced by
Portugal GroVida
Cultivated or Packaged in
Flag of Portugal Portugal
Irradiation
Beta-Irradiated
Monograph Conformity
5.1.4
Imported by
United Kingdom Eaststone
Imported as
Schedule II: Finished Product

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Confirming Details

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Product Description Video Reviews0 Patient Reviews

Further details to follow.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Lyphe Group Ltd

Noidecs Logo

From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

At Lyphe our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.

lyphegroup.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)